Features

/kidneynews/10_8/7/graphic/7f1.jpg

Tell us about your background. How long have you been with HHS?

In dialysis patients with atrial fibrillation, the factor Xa inhibitor apixaban reduced the risk of major bleeding compared to warfarin in a nationwide sample, reports a study in Circulation.

Standard-dose apixaban is also associated with lower risks of thromboembolism and death compared to warfarin.

The global burden of kidney diseases is much higher than commonly reported, according to a notice recently issued by the American Society of Nephrology (ASN), European Renal Association—European Dialysis and Transplant Association (ERA-EDTA), and International Society of Nephrology (ISN).

Fatigue is one of the most common symptoms reported by patients on dialysis, but there is little data to guide clinicians about how to manage it. A new initiative aims to change that by helping researchers routinely and consistently measure fatigue in their studies of dialysis-related care.

As a dialysis patient and peer coach, Caroline Wilkie knows how postdialysis fatigue and cramping can get in the way of socializing, work, or other responsibilities.

“A lot of us don’t plan things in advance because we never know how tired we’re going to be,” Wilkie said.

Pages